Loading...
The group II metabotropic glutamate receptor agonist, LY379268, decreases methamphetamine self-administration in rats
BACKGROUND: Given the problems associated with the escalation in methamphetamine (METH) use, the identification of more effective treatment strategies is essential. Group II metabotropic glutamate receptors (mGluRs) have been suggested to be a novel therapeutic target for psychostimulant addiction....
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2013
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3804156/ https://ncbi.nlm.nih.gov/pubmed/23953655 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2013.07.024 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|